How does 9572's PS Ratio compare to its peers?

9572 is good value based on its Price-To-Sales Ratio (1.4x) compared to the peer average (2.3x).

How does 9572's PS Ratio compare vs other companies in the SA Healthcare Industry?

9572 is good value based on its Price-To-Sales Ratio (1.4x) compared to the SA Healthcare industry average (4.5x).

What is 9572's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 9572's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of 9572 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

9572 (SAR57.7) is trading below our estimate of [[fair value]] (SAR355.78)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

9572 Stock Overview

Engages in supplying medical equipment in Saudi Arabia. More details

9572 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	1/6
Financial Health	4/6
Dividends	1/6

Rewards

Trading at 83.8% below our estimate of its fair value

Revenue grew by 5.3% over the past year

Risk Analysis

Highly volatile share price over the past 3 months compared to the SA market

Profit margins (0.1%) are lower than last year (3.5%)

Does not have a meaningful market cap (SAR88M)

My Notes

Capture your thoughts, links and company narrative

Al-Razi Medical Company Competitors

Professional Medical Expertise

SASE:9574

ر.س315.0m

Qomel

SASE:9600

ر.س420.0m

Arabian International Healthcare Holding

SASE:9530

ر.س799.5m

Alf Meem Yaa for Medical Supplies and Equipment

SASE:9527

ر.س875.0m

Price History & Performance

Summary of share price highs, lows and changes for Al-Razi Medical
Historical stock prices
Current Share Price	ر.س57.70
52 Week High	ر.س61.70
52 Week Low	ر.س41.10
Beta	0
1 Month Change	3.22%
3 Month Change	25.43%
1 Year Change	1.23%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	58.52%

Recent updates

Shareholder Returns

	9572	SA Healthcare	SA Market
7D	1.9%	0.4%	-1.2%
1Y	1.2%	-6.1%	-10.9%

Return vs Industry: 9572 exceeded the SA Healthcare industry which returned -6.1% over the past year.

Return vs Market: 9572 exceeded the SA Market which returned -11% over the past year.

Price Volatility

Is 9572's price volatile compared to industry and market?
9572 volatility
9572 Average Weekly Movement	8.0%
Healthcare Industry Average Movement	5.0%
Market Average Movement	3.9%
10% most volatile stocks in SA Market	7.9%
10% least volatile stocks in SA Market	2.4%

Stable Share Price: 9572's share price has been volatile over the past 3 months compared to the SA market.

Volatility Over Time: 9572's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of SA stocks.

About the Company

Founded	Employees	CEO	Website
1986	123	n/a	www.razimed.com

Al-Razi Medical Company engages in supplying medical equipment in Saudi Arabia. It sells hospital beds, steam and suction devices, inhalation devices, masks, needles, oxygen masks, water bladders, bandages, gloves, and ear rings and piercings. The company serves hospitals, clinics, medical centers, medical companies, and pharmacies.

Al-Razi Medical Company Fundamentals Summary

How do Al-Razi Medical's earnings and revenue compare to its market cap?
9572 fundamental statistics
Market cap	ر.س87.70m
Earnings (TTM)	ر.س89.78k
Revenue (TTM)	ر.س61.99m

976.9x

P/E Ratio

1.4x

P/S Ratio

Is 9572 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9572 income statement (TTM)
Revenue	ر.س61.99m
Cost of Revenue	ر.س45.66m
Gross Profit	ر.س16.34m
Other Expenses	ر.س16.25m
Earnings	ر.س89.78k

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.059
Gross Margin	26.35%
Net Profit Margin	0.14%
Debt/Equity Ratio	10.1%

How did 9572 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

43%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 23:55
End of Day Share Price	2024/12/30 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Al-Razi Medical Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Al-Razi Medical SASE:9572 Stock Report